Urate
Biomarker4 papers1 finding
- Human trial1
- Humans2
- Model organisms1
Interventions
1Dapagliflozin
downin humans1Moderate certainty
1 study
Dapagliflozin
downin humans1Moderate certainty
Dapagliflozin decreases urate in humans (P-interaction < 0.001).
Human trialPAH or CTEPH on background vasodilator therapyserum10 mg daily12 weeksn = 52
Dapagliflozin in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: The DAPAH randomized controlled trial · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 31 Aug 2026
Latest
16Uric acid salt linked to high-risk plaque in heart arteries
In an observational study of 116 patients, detected urate was linked to odds of high-risk plaque 4.91 times those without detected urate.In an observational study of 116 patients, detected urate was linked to odds of high-risk plaque 4.91 times those without detected urate.